Events

Piper Sandler 33rd Annual Healthcare Conference
Presentation by Dr. Cory Nicholas, President and CEO
Monday, November 22, 2021 
Watch the recording.

Press Releases

Neurona Therapeutics to Present New Preclinical Data and Clinical Trial Plans for Lead Neural Cell Therapy Program, NRTX-1001, at the Annual Meeting of the American Epilepsy Society
December 3, 2021

Neurona Therapeutics to Present at the Piper Sandler 33rd Annual Healthcare Conference
November 18, 2021

Neurona Therapeutics Presents Preclinical Data from Lead Cell Therapy Candidate NRTX-1001 at Neuroscience 2021.
November 8, 2021

Neurona Therapeutics Receives IND Clearance to Initiate Phase 1/2 Clinical Trial of Neural Cell Therapy NRTX-1001 in Chronic Focal Epilepsy Patients.
November 4, 2021

Neurona Therapeutics Appoints Brad Margus to its Board of Directors
October 20, 2021

Neurona Therapeutics Raises $41.5M to Advance Neural Network-Rebalancing Cell Therapies for the Treatment of Epilepsy and other Neurological Disorders

June 22, 2021

Neurona Therapeutics Presents Clinical Development Plan for Lead Cell Therapy Program at the 16th Conference on Antiepileptic Drug and Device Trials (AEDD TRIALS XVI
June 16, 2021

Neurona Therapeutics Presents Preclinical Data from Lead Inhibitory Cell Therapy Program, Demonstrating Significant Seizure Suppression in Model of Focal Epilepsy
April 19, 2021

Neurona Therapeutics awarded a $4.8M translational grant from CIRM to advance epilepsy program to the pre-IND stage
October 31, 2019

CIRM Discovery Quest Award program: Neurona Therapeutics receives funding
December 14, 2017 

Neurona Therapeutics Launches with $23.5 Million in Series A Funding to Repair Damaged Neural Circuits
December 1, 2015

In the news

Promising new approach for people with epilepsy
November 9, 2021

Focal Epilepsy Cell Therapy NRTX-1001 Gets IND Clearance, Set to Begin Phase 1/2 Trial
November 9, 2021

A Mind For Medicine. Researchers are tapping into the regenerative power of stem cells to treat central nervous system disorders.
September24, 2021 

Neurona Therapeutics is dashing to the clinic with its cell therapy for epilepsy — but first, another venture round
June 23, 2021

Transplanting Specialized Neurons Cory R Nicholas, PhD, Co-Founder and CEO of Neurona Therapeutics, talks to Pharmafile about the world of neurological disorders and transplantation. (This article is taken from Pharmafile Spring 2021, pages 54-55. © Samedan Ltd)
May 19, 2021

Human Neuron Transplants Treat Spinal Cord Injury in Mice
September 22, 2016 

The Daily Startup: How This VC Firm is Building Its Own Biotech Companies
May 4, 2015

Stem cells to transplant in the brain: Stealth UCSF spinout Neurona Therapeutics raises $7.6M
December 24, 2014

Successful transplantation of lab-derived interneurons in mice
May 07, 2013

Epileptic mice cured with transplantation of MGE interneurons
May 07, 2013

Reining in pain
June 21, 2012

Progenitor cell therapy for epilepsy
September 10, 2009